UNSW Pharmaceutical Medicine

Orin Chisholm

Associate Professor Orin Chisholm

BSc (Hons), GCULT, PhD, SFHEA

Program Authority and Associate Professor in Pharmaceutical Medicine, School of Medical Sciences, UNSW Sydney

Orin Chisholm is the Program Director and Associate Professor in Pharmaceutical Medicine in the School of Medical Sciences at UNSW.

Orin is a member of the Gene Technology Technical Advisory Committee which provides advice to the Gene Technology Regulator, the OGTR and the Legislative Governance Forum on Gene Technology on all matters relating to gene technology, genetically-modified organisms (GMOs) and genetically modified (GM) products, including applications made to the Regulator under the Act, the biosafety aspects of gene technology and the need for and content of policy principles, guidelines, codes of practice and technical and procedural guidelines in relation to GMOs and GM products in Australia.

She has extensive experience in the pharmaceutical industry, which has equipped her to embed practical, current and innovative education in pharmaceutical medicine in her role as program director. She has worked predominantly in regulatory affairs in both large multinational pharmaceutical and smaller biotechnology companies in Australia.   She has particular expertise in the registration of biotechnology products for oncology indications. She contributes her expertise in global regulatory affairs to a text on international regulatory affairs published by RAPS and sits on the Editorial Advisory Committee for RAPS. She is the Chair of the ANZ Regional Advisory Committee for DIA.

Orin also has a strong academic background in the molecular biology of haemopoiesis and oncology and she has teaching qualifications in higher education. She has received a Faculty teaching award for outstanding contributions to student learning, a TOPRA award for Regulatory Affairs Education and is a Senior Fellow of the Higher Education Academy of the UK.

Orin is a member of ARCS, ASCEPT, DIA, RAPS, TOPRA and HERDSA.

 


 

 

Dr Johnson Liu

BSc, GCULT, MSc, PhD

Lecturer, Pharmaceutical Medicine and Pharmacology, School of Medical Sciences, UNSW Sydney

After completion of his BSc, MSc and PhD in Pharmacology at South China Agricultural University and postdoctoral training in Clinical Pharmacology at the University of Auckland, Johnson has taken up academic positions at the University of Auckland, Auckland University of Technology, University of Tasmania and now at UNSW. He has extensive teaching experience in pharmaceutical sciences, pharmacology, medicines development and regulations for undergraduate and postgraduate courses. Johnson has completed his Graduate Certificate in University Teaching and Learning.

His research involves studies on drug transporter, cancer cell signalling, pharmacokinetics, drug development, systems pharmacology and chemotherapy-induced neuropathy, which are supported by public and commercial funding grants. He has co-authored >35 peer-reviewed research articles. He is a review editor and an expert reviewer for several international journals. He is a member of the Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists (ASCEPT) and the American Association of Cancer Research (AACR). He has supervised over a dozen postgraduate students with thesis topics in cancer pharmacology. Johnson has research interests in cancer pharmacology, molecular pharmacology, experimental therapeutics, pharmacokinetics, drug transport & delivery, targeted therapy and systems pharmacology.

November 2018

The Pharmaceutical Medicine team delivered a very successful 1-day Law Masterclass entitled: Therapeutic Good Regulation in Australia: the Challenge of Change

September 2018

Students of Pharmaceutical Medicine program took a trip to the Therapeutic Goods Administration office in Canberra on 13-14 September 2018, where they attended a series of talks and connected with their peers.

June 2018

UNSW Medicine alumna Elizabeth de Somer has been appointed CEO of Medicines Australia.

View the full story here

image - News

November 2017

Dr Chisholm has won the TOPRA Award for Excellence in Regulatory Affairs Education for 2017.

October 2017

Congratulations to Dr Orin Chisholm for her nomination for the award in Excellence in Regulatory Affairs Education from The Organisation for Professionals in Regulatory Affairs (TOPRA).

TOPRA is based in the UK and is an international professional membership organisation for individuals who work in healthcare regulatory affairs. The organisation enables connections and promotes excellence across the healthcare regulatory affairs profession. The winners will be announced at this year’s ceremony which will be held at the Waldorf Hilton in London on 8 November 2017.

September 2017

Very satisfied participants after our 2-day Pharmaceutical Medicine training program for pharmacists from Shandong Province, China.

Students enjoying a tour of the TGA laboratories.

December 2016

Please see the highlights reel from the day below.

 

Best wishes to you all from the Pharmaceutical Medicine team for the holiday period and the new year!

September 2016

Members of the 2016 Pharmaceutical Medicine cohort recently took a trip to the Therapeutic Goods Administration offices in Canberra, where they met members of staff and connected with their peers.

image - News

May 2015

Dr Chisholm and Jan Cooper attended a very successful ARCS Conference at Randwick Racecourse on 5 - 7 May.  

April 2014

Dr Chisholm & Jan Cooper attended the Pharmaceutical Sciences World Congress in Melbourne from 13 – 16 April

iamge - news

June 2013

Dr Chisholm and Jan Cooper had a very successful time at the ARCS Conference in Sydney on 5 and 6 June.

image - News

April 2013

Dr Chisholm hosted a delegation from the Shaanxi Institute for Food and Drug Control, People’s Republic of China, discussing the regulation of medicines in Australia. Another very successful Weekend School was held at the UNSW campus on 13 and 14 April.

March 2013

Dr Chisholm outlined the Pharmaceutical Medicine and Drug Development programs in the recent edition of “The Source”, a publication by ARCS Australia Ltd, the professional development association for individuals involved in the development of therapeutic products.